市場調查報告書
商品編碼
1608717
臉部回春市場:依產品類型、最終用戶、地區Facial Rejuvenation Market, By Product Type (Topical Rejuvenation Products and Equipment ), By End User, By Geography |
預計2024年臉部回春市場規模將達281.4億美元,2024年至2031年複合年成長率為7.9%,2031年將達到478.8億美元。
分析範圍 | 分析詳情 | ||
---|---|---|---|
基準年 | 2023年 | 市場規模(2024年) | 281.4億美元 |
實際資料 | 2019-2023 | 預測期 | 2024-2031 |
預測期複合年成長率(2024-2031): | 7.90% | 預計金額(2031年) | 478.8億美元 |
由於對恢復青春的美容手術的需求不斷增加,全球臉部回春市場正在穩步成長。臉部回春療程有助於減少皮膚下垂、細紋和皺紋,並恢復臉部豐盈度和豐滿度。人們越來越喜歡非侵入性治療而不是手術方法,加上技術先進的產品和治療方法的出現,可以推動市場成長。然而,整容手術的高成本可能會阻礙這種治療的廣泛使用。新興經濟體的美容意識和治療接受度正在大幅成長,這將在預測期內開闢新的成長途徑。
微創治療的日益普及、可支配收入的增加、容易受到與老齡化相關的面部變化的老年人口的增加以及新興國家醫療旅遊業的快速成長正在推動市場的發展。然而,整容手術的高成本和缺乏報銷政策可能會阻礙市場擴張。雷射表面置換、神經調節劑和真皮填充劑等新技術和設備的引入使得複雜病例的治療成為可能,並開闢了新的機會。製造商正在積極投資研發,以開發副作用較少的更好產品。
本報告的主要特點
該報告對全球臉部回春市場進行了詳細分析,估計了以2023年為基準年的預測期(2024-2031年)的市場規模(十億美元)和年複合成長率(CAGR,%)。
它還揭示了各個細分市場的潛在商機,並為該市場說明了一系列有吸引力的投資提案。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的主要考察。
我們根據以下參數對全球臉部回春市場的主要企業進行了分析:公司亮點、產品系列、主要亮點、財務表現、策略等。
本報告涵蓋的主要企業包括 Merz Pharma、Anika Therapeutics、Lumenis、Galderma、AbbVie、Contura Ltd、Fibrocell Science、Revance Therapeutics、Cynosure、Alma Lasers 和 STRATA Skin Sciences、Sciton、Elevai Labs 和 SkinBioTherapeutics。
該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球臉部回春市場報告針對該行業的各個相關人員,如投資者、供應商、產品製造商、經銷商、新進入者和財務分析師。
Facial rejuvenation market is estimated to be valued at USD 28.14 Bn in 2024 and is expected to reach USD 47.88 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 7.9% from 2024 to 2031.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2023 | Market Size in 2024: | 28.14 Bn |
Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
Forecast Period 2024 to 2031 CAGR: | 7.90% | 2031 Value Projection: | 47.88 Bn |
Global facial rejuvenation market has been witnessing steady growth, owing to rising demand for aesthetic procedures among people to restore youthful appearance. Facial rejuvenation treatments help reduce sagging skin, fine lines, wrinkles and restore volume and fullness to face. Growing preference for non-invasive procedures over surgical methods along with availability of technologically advanced products and treatments can drive the market growth. However, high cost of aesthetic procedures can hamper the widespread adoption of this treatment. Aesthetic awareness and acceptance of cosmetic treatments have increased considerably in emerging economies, thus, offering new avenues of growth over the forecast period.
Rising popularity of minimally invasive treatments, increasing disposable incomes, growing geriatric population susceptible to age-related facial changes and surge in medical tourism in developing nations can drive the market growth. However, high costs associated with aesthetic procedures and lack of reimbursement policies can hamper the market expansion. Introduction of novel technologies and equipment like laser resurfacing, neuromodulators and dermal fillers have opened new opportunities, enabling treatment of complex cases. Manufacturers are actively investing in R&D to develop superior products with reduced adverse effects.
Key features of the study
This report provides in-depth analysis of the global facial rejuvenation market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global facial rejuvenation market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Merz Pharma, Anika Therapeutics, Lumenis, Galderma, AbbVie, Contura Ltd, Fibrocell ScienceInc., Revance Therapeutics, Cynosure, Alma Lasers, STRATA Skin Sciences, Sciton, Inc., Elevai Labs, Inc., and SkinBioTherapeutics
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global facial rejuvenation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts